Related Experiment Videos

Endogenous Candida endophthalmitis after intravenous anesthesia with propofol

M J Daily1, J B Dickey, K H Packo

  • 1Department of Ophthalmology, Loyola University Medical Center, Maywood, IL 60153.

Insights

Propofol, a widely used anesthetic, was linked to postsurgical infections. Contaminated propofol during preparation caused Candida albicans endophthalmitis in non-immunocompromised patients.

Area of Science:

  • Anesthesiology
  • Infectious Diseases
  • Ophthalmology

Background:

  • Propofol, an intravenous anesthetic, gained widespread use after FDA approval in 1989.
  • The Centers for Disease Control reported clusters of postsurgical infections linked to propofol in 1990.
  • Endogenous endophthalmitis is a serious intraocular infection.

Purpose of the Study:

  • To describe a specific cluster of postsurgical infections associated with propofol.
  • To identify the causative agent and source of these infections.
  • To raise awareness among ophthalmologists about a potential new source of endogenous endophthalmitis.

Main Methods:

  • Case series describing four patients with endogenous Candida albicans endophthalmitis.
  • Investigation by the Centers for Disease Control to determine the cause of infection.
  • Analysis of patient history, surgical procedures, and anesthetic agents used.

Main Results:

  • Four non-immunocompromised patients developed Candida albicans endophthalmitis post-nonophthalmologic surgery.
  • Propofol was used as the anesthetic agent in all cases.
  • The Centers for Disease Control investigation concluded extrinsic contamination of propofol during hospital preparation was the cause.

Conclusions:

  • Extrinsic contamination of propofol during preparation is a potential cause of endogenous endophthalmitis.
  • Ophthalmologists should consider propofol contamination as a source of postsurgical endophthalmitis.
  • This highlights the importance of aseptic techniques in anesthetic preparation.

Related Concept Videos